1-4 of 4
Joseph J. Kaberlein
Close
Sort by
Journal Articles

Lymphoid Lineage Preference of MLL-AF4 Is Revealed in a Species-Specific Model

Shan Lin, Roger T. Luo, PhD, Mark Wunderlich, MS, Joseph J. Kaberlein, Ahmad Rayes, MDMSc, John Anastasi, MD, Maureen M O'Brien, MD, James C. Mulloy, PhD, Michael J. Thirman, MD
Journal: Blood
Blood (2015) 126 (23): 2454.
https://doi.org/10.1182/blood.V126.23.2454.2454
Published: 2015
Journal Articles

MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome

Qian-fei Wang, George Wu, Shuangli Mi, Fuhong He, Jun Wu, Jingfang Dong, Roger T. Luo, Ryan Mattison, Joseph J. Kaberlein, Shyam Prabhakar, Hongkai Ji, Michael J. Thirman
Journal: Blood
Blood (2011) 117 (25): 6895–6905.
https://doi.org/10.1182/blood-2010-12-324699
Published: 2011
Includes: Supplemental data
Journal Articles

ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties

Federico Simone, Roger T. Luo, Paul E. Polak, Joseph J. Kaberlein, Michael J. Thirman
Journal: Blood
Blood (2003) 101 (6): 2355–2362.
https://doi.org/10.1182/blood-2002-06-1664
Published: 2003
Journal Articles

EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein

Federico Simone, Paul E. Polak, Joseph J. Kaberlein, Roger T. Luo, Denise A. Levitan, Michael J. Thirman
Journal: Blood
Blood (2001) 98 (1): 201–209.
https://doi.org/10.1182/blood.V98.1.201
Published: 2001